Related Experiment Video
Updated: Mar 17, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
The association between inflammatory indices and acute pancreatitis severity: a retrospective cohort study
Huicong Ma1, Na Li1, Huaisheng Zhang2
1Institute of Emergency and Critical Care Medicine, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong, China.
Background:
Acute pancreatitis (AP) is a heterogeneous inflammatory disease, with ∼20% of patients progressing to moderate-to-severe (MSAP) or severe AP (SAP), conditions associated with high mortality. Early risk stratification is therefore critical. This study systematically evaluated and compared 12 inflammatory biomarkers for predicting AP severity.
Methods:
This retrospective cohort included 1,981 hospitalized AP patients (January 2018-December 2023). According to the revised Atlanta criteria, patients were classified into mild AP (MAP, n = 1,058) and MSAP/SAP (n = 923) groups. Twelve inflammatory indices-monocyte-to-lymphocyte ratio (MLR), lymphocyte-to-monocyte ratio (LMR), C-reactive protein-to-albumin ratio (CAR), C-reactive protein-albumin-lymphocyte index (CALLY), C-reactive protein-to-calcium ratio (CCR), C-reactive protein-to-lymphocyte ratio (CLR), red cell distribution width-to-albumin ratio (RDW/Alb), neutrophil-to-albumin ratio (NAR), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII)-were calculated. A multivariate logistic regression model adjusted for 28 covariates. ROC curves assessed predictive performance; restricted cubic splines (RCS) explored nonlinear relationships; and threshold effect analysis was conducted for the highest-performing biomarker.
Results:
In the fully adjusted model, nine biomarkers were significantly associated with MSAP/SAP risk: MLR (OR = 1.29, 95%CI: 1.15-1.45), LMR (OR = 0.75, 95%CI: 0.66-0.85), CAR (OR = 3.82, 95%CI: 3.18-4.64), CALLY (OR = 0.56, 95%CI: 0.49-0.64), CCR (OR = 4.84, 95%CI: 3.98-5.96), CLR (OR = 2.12, 95%CI: 1.84-2.46), RDW/Alb (OR = 1.74, 95%CI: 1.54-1.99), NAR (OR = 1.44, 95%CI: 1.27-1.64), and SIRI (OR = 1.29, 95%CI: 1.15-1.46). CCR demonstrated the highest observed accuracy (AUC = 0.768, 95%CI: 0.737-0.799). Threshold effect analysis revealed a nonlinear association, with an inflection point at 15: no significant association was observed below this threshold (OR = 1.015, P = 0.558), whereas risk significantly increased above it (OR = 1.212, P < 0.001).
Conclusion:
Among 12 inflammatory biomarkers, CCR showed the strongest predictive value for MSAP/SAP, with a critical threshold of 15. As an easily obtainable marker, CCR may serve as a practical early warning tool to guide clinical management and risk stratification in AP.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammation
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

